S&P 500   4,538.43 (-0.84%)
DOW   34,580.08 (-0.17%)
QQQ   383.13 (-1.74%)
AAPL   161.84 (-1.17%)
MSFT   323.01 (-1.97%)
FB   306.84 (-1.14%)
GOOGL   2,840.03 (-0.67%)
AMZN   3,389.79 (-1.38%)
TSLA   1,014.97 (-6.42%)
NVDA   306.93 (-4.46%)
BABA   111.96 (-8.23%)
NIO   32.15 (-11.19%)
CGC   9.99 (-3.57%)
AMD   144.01 (-4.43%)
GE   92.77 (-2.58%)
MU   81.62 (-1.52%)
T   23.46 (+1.78%)
F   19.14 (-3.67%)
DIS   146.22 (-0.67%)
PFE   54.27 (+2.32%)
AMC   29.01 (-4.19%)
ACB   5.82 (-5.21%)
BA   198.49 (-1.92%)
S&P 500   4,538.43 (-0.84%)
DOW   34,580.08 (-0.17%)
QQQ   383.13 (-1.74%)
AAPL   161.84 (-1.17%)
MSFT   323.01 (-1.97%)
FB   306.84 (-1.14%)
GOOGL   2,840.03 (-0.67%)
AMZN   3,389.79 (-1.38%)
TSLA   1,014.97 (-6.42%)
NVDA   306.93 (-4.46%)
BABA   111.96 (-8.23%)
NIO   32.15 (-11.19%)
CGC   9.99 (-3.57%)
AMD   144.01 (-4.43%)
GE   92.77 (-2.58%)
MU   81.62 (-1.52%)
T   23.46 (+1.78%)
F   19.14 (-3.67%)
DIS   146.22 (-0.67%)
PFE   54.27 (+2.32%)
AMC   29.01 (-4.19%)
ACB   5.82 (-5.21%)
BA   198.49 (-1.92%)
S&P 500   4,538.43 (-0.84%)
DOW   34,580.08 (-0.17%)
QQQ   383.13 (-1.74%)
AAPL   161.84 (-1.17%)
MSFT   323.01 (-1.97%)
FB   306.84 (-1.14%)
GOOGL   2,840.03 (-0.67%)
AMZN   3,389.79 (-1.38%)
TSLA   1,014.97 (-6.42%)
NVDA   306.93 (-4.46%)
BABA   111.96 (-8.23%)
NIO   32.15 (-11.19%)
CGC   9.99 (-3.57%)
AMD   144.01 (-4.43%)
GE   92.77 (-2.58%)
MU   81.62 (-1.52%)
T   23.46 (+1.78%)
F   19.14 (-3.67%)
DIS   146.22 (-0.67%)
PFE   54.27 (+2.32%)
AMC   29.01 (-4.19%)
ACB   5.82 (-5.21%)
BA   198.49 (-1.92%)
S&P 500   4,538.43 (-0.84%)
DOW   34,580.08 (-0.17%)
QQQ   383.13 (-1.74%)
AAPL   161.84 (-1.17%)
MSFT   323.01 (-1.97%)
FB   306.84 (-1.14%)
GOOGL   2,840.03 (-0.67%)
AMZN   3,389.79 (-1.38%)
TSLA   1,014.97 (-6.42%)
NVDA   306.93 (-4.46%)
BABA   111.96 (-8.23%)
NIO   32.15 (-11.19%)
CGC   9.99 (-3.57%)
AMD   144.01 (-4.43%)
GE   92.77 (-2.58%)
MU   81.62 (-1.52%)
T   23.46 (+1.78%)
F   19.14 (-3.67%)
DIS   146.22 (-0.67%)
PFE   54.27 (+2.32%)
AMC   29.01 (-4.19%)
ACB   5.82 (-5.21%)
BA   198.49 (-1.92%)
NYSE:LCI

Lannett Stock Forecast, Price & News

$1.78
+0.08 (+4.71%)
(As of 12/3/2021 04:00 PM ET)
Add
Compare
Today's Range
$1.65
$1.79
50-Day Range
$1.56
$3.17
52-Week Range
$1.53
$10.70
Volume
417,697 shs
Average Volume
731,672 shs
Market Capitalization
$76.55 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.97
30 days | 90 days | 365 days | Advanced Chart
Receive LCI News and Ratings via Email

Sign-up to receive the latest news and ratings for Lannett and its competitors with MarketBeat's FREE daily newsletter.


Lannett logo

About Lannett

Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Trevose, PA.

Headlines

Contrasting Viking Therapeutics (NASDAQ:VKTX) & Lannett (NYSE:LCI)
November 12, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceuticals
Sector
Medical
CUSIP
51601210
Employees
954
Year Founded
N/A

Sales & Book Value

Annual Sales
$478.78 million
Cash Flow
$1.17 per share
Book Value
($0.66) per share

Profitability

Net Income
$-363.48 million
Pretax Margin
-68.48%

Debt

Price-To-Earnings

Miscellaneous

Free Float
37,143,000
Market Cap
$76.55 million
Optionable
Optionable

Company Calendar

Last Earnings
11/03/2021
Today
12/03/2021
Next Earnings (Estimated)
2/02/2022
Fiscal Year End
6/30/2022

MarketRank

Overall MarketRank

2.34 out of 5 stars

Medical Sector

248th out of 1,391 stocks

Pharmaceutical Preparations Industry

104th out of 669 stocks

Analyst Opinion: 3.0Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 4.2Valuation: 0.0 5 -4 -3 -2 -1 -












Lannett (NYSE:LCI) Frequently Asked Questions

Is Lannett a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Lannett in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Lannett stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in LCI, but not buy additional shares or sell existing shares.
View analyst ratings for Lannett
or view top-rated stocks.

How has Lannett's stock been impacted by Coronavirus?

Lannett's stock was trading at $7.74 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, LCI shares have decreased by 77.0% and is now trading at $1.78.
View which stocks have been most impacted by COVID-19
.

When is Lannett's next earnings date?

Lannett is scheduled to release its next quarterly earnings announcement on Wednesday, February 2nd 2022.
View our earnings forecast for Lannett
.

How were Lannett's earnings last quarter?

Lannett Company, Inc. (NYSE:LCI) announced its quarterly earnings results on Wednesday, November, 3rd. The company reported ($0.27) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.25) by $0.02. Lannett had a negative net margin of 83.58% and a negative trailing twelve-month return on equity of 31.06%. During the same period in the prior year, the company earned $0.06 earnings per share.
View Lannett's earnings history
.

What guidance has Lannett issued on next quarter's earnings?

Lannett updated its FY 2022 earnings guidance on Wednesday, November, 17th. The company provided EPS guidance of for the period. The company issued revenue guidance of $370 million-$400 million, compared to the consensus revenue estimate of $430.15 million.

What price target have analysts set for LCI?

1 analysts have issued 12-month target prices for Lannett's shares. Their forecasts range from $6.00 to $6.00. On average, they expect Lannett's share price to reach $6.00 in the next year. This suggests a possible upside of 237.1% from the stock's current price.
View analysts' price targets for Lannett
or view top-rated stocks among Wall Street analysts.

Who are Lannett's key executives?

Lannett's management team includes the following people:
  • Timothy C. Crew, Chief Executive Officer & Director
  • John M. Abt, Chief Operations & Quality Officer, Vice President
  • John Kozlowski, CFO, Principal Accounting officer & VP-Finance
  • Robert Ehlinger, Chief Information Officer & VP-Logistics
  • Maureen M. Cavanaugh, Chief Commercial Operations Officer & Senior VP

What is Timothy Crew's approval rating as Lannett's CEO?

9 employees have rated Lannett CEO Timothy Crew on Glassdoor.com. Timothy Crew has an approval rating of 28% among Lannett's employees. This puts Timothy Crew in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Lannett own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Lannett investors own include (CELG), Akorn (AKRX), Skechers U.S.A. (SKX), Integrated Device Technology (IDTI), Bank of America (BAC), Alibaba Group (BABA), Gilead Sciences (GILD), Micron Technology (MU), Rite Aid (RAD) and NVIDIA (NVDA).

What is Lannett's stock symbol?

Lannett trades on the New York Stock Exchange (NYSE) under the ticker symbol "LCI."

Who are Lannett's major shareholders?

Lannett's stock is owned by a variety of retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (4.65%), HealthInvest Partners AB (4.20%), LSV Asset Management (4.04%), Millennium Management LLC (2.15%), Dimensional Fund Advisors LP (2.01%) and BlackRock Inc. (1.53%). Company insiders that own Lannett stock include David A Drabik, Jeffrey Farber, John Kozlowski, Patrick G Lepore and Timothy C Crew.
View institutional ownership trends for Lannett
.

Which major investors are selling Lannett stock?

LCI stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Dimensional Fund Advisors LP, Squarepoint Ops LLC, Cubist Systematic Strategies LLC, LSV Asset Management, Millennium Management LLC, Citadel Advisors LLC, and Bank of New York Mellon Corp.
View insider buying and selling activity for Lannett
or view top insider-selling stocks.

Which major investors are buying Lannett stock?

LCI stock was acquired by a variety of institutional investors in the last quarter, including HealthInvest Partners AB, Assenagon Asset Management S.A., Connor Clark & Lunn Investment Management Ltd., Renaissance Technologies LLC, Staley Capital Advisers Inc., Two Sigma Investments LP, Geode Capital Management LLC, and Two Sigma Advisers LP. Company insiders that have bought Lannett stock in the last two years include Jeffrey Farber, John Kozlowski, Patrick G Lepore, and Timothy C Crew.
View insider buying and selling activity for Lannett
or or view top insider-buying stocks.

How do I buy shares of Lannett?

Shares of LCI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Lannett's stock price today?

One share of LCI stock can currently be purchased for approximately $1.78.

How much money does Lannett make?

Lannett has a market capitalization of $76.55 million and generates $478.78 million in revenue each year. The company earns $-363.48 million in net income (profit) each year or ($9.60) on an earnings per share basis.

How many employees does Lannett have?

Lannett employs 954 workers across the globe.

What is Lannett's official website?

The official website for Lannett is www.lannett.com.

Where are Lannett's headquarters?

Lannett is headquartered at 9000 STATE ROAD, PHILADELPHIA PA, 19136.

How can I contact Lannett?

Lannett's mailing address is 9000 STATE ROAD, PHILADELPHIA PA, 19136. The company can be reached via phone at (215) 333-9000 or via fax at 215-333-9004.


This page was last updated on 12/3/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.